PNC Financial Services Group
LBRX icon

PNC Financial Services Group’s LB Pharmaceuticals LBRX Stock Holding History

PNC Financial Services Group’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.4K Sell
272
-4
-1% -$165 ﹤0.01% 4156
2026
Q2 		$8.96K Buy
276
+131
+90% +$3.85K ﹤0.01% 4142
2026
Q1 		$3.58K Buy
+145
New +$3.34K ﹤0.01% 4405

Other funds holding LBRX

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Longbow Finance
Longbow Finance Lutry, Switzerland $850M AUM 42.98% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
NEXTBio Capital Management
NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return

PNC Financial Services Group's LBRX Position: Q3 2026 in Review

PNC Financial Services Group reduced its LB Pharmaceuticals (LBRX) stake by 1.4% in Q3 2026, selling an estimated $165 and leaving 272 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4156.

PNC Financial Services Group first reported a position in LBRX in Q1 2026 and has held it in 3 quarters since. 67 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • PNC Financial Services Group held 272 shares of LB Pharmaceuticals worth $10.4K as of Q3 2026.
  • PNC Financial Services Group sold 4 LB Pharmaceuticals shares in Q3 2026, an estimated $165.
  • LB Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4156 holding.
  • PNC Financial Services Group first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 67 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.